CDX-2 is a caudal-related homeobox transcription factor that is expressed by intestinal epithelial cells. CDX-2 is a useful marker for gastrointestinal carcinoma and for determining the origin of gastrointestinal metastatic adenocarcinoma and carcinoid tumours. Anti-CDX-2 is used for differentiating lung and metastatic colorectal adenocarcinoma. However, mucinous ovarian carcinoma also reacts positively with Anti-CDX-2, thereby limiting the ability to differentiate from metastatic colorectal adenocarcinoma.

• CDX2 Datasheet IVDR

• MSDS
• 2021 NordiQC Assessment Report for IHC302: Good
• GeneAb™ IHC Antibodies ranked Optimal by NordiQC

CLONE:
IHC302

ISOTYPE:
IgG

HOST SPECIES:
Rabbit

CLONALITY:
Monoclonal

POSITIVE CONTROL:
Colon

DILUTION RANGE:


INTENDED USE/REG. STATUS:
IVDR

ADDITIONAL INFORMATION:
NordiQC Rating: Good
(Assessment Run 61 2021)